Pharmacology of Iron Transport

被引:25
作者
Byrne, Shaina L. [1 ]
Krishnamurthy, Divya [1 ]
Wessling-Resnick, Marianne [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 | 2013年 / 53卷
关键词
hepcidin; hemochromatosis; transferrin; DMT1; NTBI; CELL LUNG-CANCER; PYRIDOXAL ISONICOTINOYL HYDRAZONE; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP; AMYLOID PRECURSOR PROTEIN; TRANSFERRIN-BOUND IRON; RIBONUCLEOTIDE REDUCTASE INHIBITOR; RECEPTOR-MEDIATED ENDOCYTOSIS; DIVALENT METAL TRANSPORTER-1; SMALL-MOLECULE INHIBITORS; FREE-RADICAL REACTIONS;
D O I
10.1146/annurev-pharmtox-010611-134648
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Elucidating the molecular basis for the regulation of iron uptake, storage, and distribution is necessary to understand iron homeostasis. Pharmacological tools are emerging to identify and distinguish among different iron transport pathways. Stimulatory or inhibitory small molecules with effects on iron uptake can help characterize the mechanistic elements of iron transport and the roles of the transporters involved in these processes. In particular, iron chelators can serve as potential pharmacological tools to alleviate diseases of iron overload. This review focuses on the pharmacology of iron transport, introducing iron transport membrane proteins and known inhibitors.
引用
收藏
页码:17 / 36
页数:20
相关论文
共 173 条
  • [21] The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
    Camaschella, C
    Roetto, A
    Cali, A
    De Gobbi, M
    Garozzo, G
    Carella, M
    Majorano, N
    Totaro, A
    Gasparini, P
    [J]. NATURE GENETICS, 2000, 25 (01) : 14 - 15
  • [22] Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron
    Canonne-Hergaux, F
    Gruenheid, S
    Ponka, P
    Gros, P
    [J]. BLOOD, 1999, 93 (12) : 4406 - 4417
  • [23] Oral Iron Chelators
    Cappellini, Maria Domenica
    Pattoneri, Paolo
    [J]. ANNUAL REVIEW OF MEDICINE, 2009, 60 : 25 - 38
  • [24] A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
    Cappellini, MD
    Cohen, A
    Piga, A
    Bejaoui, M
    Perrone, S
    Agaoglu, L
    Aydinok, Y
    Kattamis, A
    Kilinc, Y
    Porter, J
    Capra, M
    Galanello, R
    Fattoum, S
    Drelichman, G
    Magnano, C
    Verissimo, M
    Athanassiou-Metaxa, M
    Giardina, P
    Kourakli-Symeonidis, A
    Janka-Schaub, G
    Coates, T
    Vermylen, C
    Olivieri, N
    Thuret, I
    Opitz, H
    Ressayre-Djaffer, C
    Marks, P
    Alberti, D
    [J]. BLOOD, 2006, 107 (09) : 3455 - 3462
  • [25] PRESENCE OF IRON CATALYTIC FOR FREE-RADICAL REACTIONS IN PATIENTS UNDERGOING CHEMOTHERAPY - IMPLICATIONS FOR THERAPEUTIC MANAGEMENT
    CARMINE, TC
    EVANS, P
    BRUCHELT, G
    EVANS, R
    HANDGRETINGER, R
    NIETHAMMER, D
    HALLIWELL, B
    [J]. CANCER LETTERS, 1995, 94 (02) : 219 - 226
  • [26] NRAMP DEFINES A FAMILY OF MEMBRANE-PROTEINS
    CELLIER, M
    PRIVE, G
    BELOUCHI, A
    KWAN, T
    RODRIGUES, V
    CHIA, W
    GROS, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) : 10089 - 10093
  • [27] Calcium channels and iron uptake into the heart
    Chattipakorn, Nipon
    Kumfu, Sirinart
    Fucharoen, Suthat
    Chattipakorn, Siriporn
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2011, 3 (07): : 215 - 218
  • [28] Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice
    Cherny, RA
    Atwood, CS
    Xilinas, ME
    Gray, DN
    Jones, WD
    McLean, CA
    Barnham, KJ
    Volitakis, I
    Fraser, FW
    Kim, YS
    Huang, XD
    Goldstein, LE
    Moir, RD
    Lim, JT
    Beyreuther, K
    Zheng, H
    Tanzi, RE
    Masters, CL
    Bush, AI
    [J]. NEURON, 2001, 30 (03) : 665 - 676
  • [29] Manganese metabolism is impaired in the Belgrade laboratory rat
    Chua, ACG
    Morgan, EH
    [J]. JOURNAL OF COMPARATIVE PHYSIOLOGY B-BIOCHEMICAL SYSTEMIC AND ENVIRONMENTAL PHYSIOLOGY, 1997, 167 (05) : 361 - 369
  • [30] CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681